PharmaLectures.com

Courses › Pharma industry foundations › Pharmacovigilance for people who are not pharmacovigilance: the QPPV, explained

Pharmacovigilance for people who are not pharmacovigilance: the QPPV, explained

Your team answers safety questions in the room, so deals and audits stop stalling.

Pharmacovigilance is the science and the legal duty of watching medicines once they are in use: collecting reports of side effects, finding patterns in them and acting on what they show. In the European Union, Directive 2001/83/EC requires every marketing authorisation holder to have a qualified person responsible for pharmacovigilance, the QPPV, who resides and operates in the EU and answers personally for the system. A supplier that never writes a safety report is still inside that system, because contracts pass the duty to report what you hear down the chain.

  • 6 audio modulesthree lengths each
  • 1 h to 5 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Management, BD, PVwho it is written for

Why pharmacovigilance training matters

A licensing partner asks for your Pharmacovigilance System Master File during due diligence. Your business development lead has never opened it. The answer waits on the Qualified Person for Pharmacovigilance, the deal sits for weeks, and the next inspection finds the same gaps.

What changes after this course

Your team answers the first safety questions itself and sends the Qualified Person only what needs a signature. Each learner completes a recorded multiple-choice questionnaire per module. You hold a certificate per learner and a training record per person to show the inspector.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

Pharmacovigilance training: what this course gives your people

Your business development lead opens a partner's Pharmacovigilance System Master File and reads it like a contract. Missing safety data exchange terms show up before signature, not after. The Good Pharmacovigilance Practices modules give your team the questions to ask, so a gap becomes a line in the negotiation instead of a surprise in the first inspection.

Marketing checks a campaign against the Risk Management Plan and the Summary of Product Characteristics before the agency sees a draft. A line such as zero side effects dies in the first review, not after a national authority writes to you. Sales reps know what counts as a safety report and pass it on the same day.

Project and quality staff send the Qualified Person for Pharmacovigilance the right data the first time. Individual Case Safety Reports go out inside the EU time limits, and the figures feeding Periodic Safety Update Reports match the case files. When an inspector asks, the Pharmacovigilance System Master File and the training record already agree.

Who needs pharmacovigilance training

  • Chief Executive Officer

    An investor asks in a funding round how the company handles safety reports. You point to a trained team, a current Pharmacovigilance System Master File and a training record, instead of promising to check.

  • Head of Business Development

    A partner asks about your safety reporting in the second meeting. You answer it yourself, and you put the same questions to their system before the term sheet is agreed.

  • Marketing Director

    The agency pitches a campaign built on few side effects. You see the conflict with the Summary of Product Characteristics and the Risk Management Plan in the meeting, and send it back.

  • Quality Assurance Manager

    A national competent authority inspector asks how a safety report reaches the Qualified Person. Your colleagues describe the route the same way, and the training record shows who was trained.

Roles: Owner, CEO and board, Business development and export sales, Pharmacovigilance and medical

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: any jurisdiction

Courses are in English. Other languages on request.

After this course your people can

  1. Decide whether a message from a doctor or customer is a reportable safety case, and name who must receive it.
  2. Send the Qualified Person for Pharmacovigilance the safety data and documents needed for oversight, in the form they ask for.
  3. Start the clock correctly on an Individual Case Safety Report and meet the submission time limit.
  4. Check a campaign or a leaflet change against the Risk Management Plan before it goes out.
  5. Review a licensing partner's Pharmacovigilance System Master File and list the gaps for the deal team.
  6. Answer an inspector's questions on how safety information moves through the company, using the records that prove it.

What the company gets

  • Safety reports from sales, marketing and partners reach the safety team on time, so cases stop sitting in inboxes.
  • Deal teams put the safety questions to a partner before signing, and gaps are priced or fixed in the contract.
  • A national competent authority inspector gets straight answers from staff outside the safety department, backed by a training record for each person.
  • Each learner holds a certificate, and the recorded questionnaire results sit in a training record you can hand over.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 6 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard2 h 30 min25 min a module, for regulatory, quality and business-development staff
Expanded5 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing1 h
Business development and export salesBriefing1 h
Pharmacovigilance and medicalStandard2 h 30 min

Pharmacovigilance course outline: 6 modules

6 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Say what EU pharmacovigilance law expects of safety teams after authorisation

    • Why authorisation is the start of your safety duties under EU pharmacovigilance law, not the end.
    • How to tell when a doctor's passing remark is a safety report your company must act on.
    • The one hand-off that stops a side effect sitting unread in a sales rep's inbox.
  2. 2Back up your Qualified Person for Pharmacovigilance in daily work

    • What your Qualified Person for Pharmacovigilance needs from you, so the late Friday calls stop.
    • How to route a safety message from an affiliate so the Qualified Person sees it the same day.
    • The Pharmacovigilance System Master File check that lets you answer a partner or inspector on the spot.
  3. 3File Individual Case Safety Reports before the regulatory deadline

    • When the clock starts on an Individual Case Safety Report, and who in your team starts it.
    • How to pass on a usable case from a customer call by getting the four minimum facts.
    • What to do when a report arrives late, so a missed deadline does not become an inspection finding.
  4. 4Draft Risk Management Plans that pass EU regulatory review

    • How to read a Risk Management Plan so your campaign never promises what the plan names as a risk.
    • What to do when a safety variation changes the leaflet and printed materials are already out.
    • The risk minimisation section that shows your team what must reach the patient, and how.
  5. 5Spot pharmacovigilance system gaps before you sign a licensing deal

    • How to ask a licensing partner for its Pharmacovigilance System Master File and spot what is missing.
    • Why a safety data exchange agreement belongs in the deal terms, not in the clean-up after signing.
    • When a gap is a point for the price and when it is a reason to walk away.
  6. 6Pass Good Pharmacovigilance Practices audits without corrective actions

    • How to brief colleagues outside the safety team for the questions an inspector asks them.
    • What a national competent authority inspector asks to see when testing your system in practice.
    • The records that close an inspection question on the day, so no corrective action plan follows.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about pharmacovigilance training

What is pharmacovigilance?

Pharmacovigilance covers the detection, assessment, understanding and prevention of adverse effects of medicines after they reach patients. It includes collecting individual case reports, submitting them to the EudraVigilance database, writing periodic safety update reports, running signal detection, keeping a risk management plan and acting when a signal is confirmed. The European rules are set out in the good pharmacovigilance practice modules published by the European Medicines Agency.

What does a QPPV do?

The qualified person responsible for pharmacovigilance is named in the pharmacovigilance system master file and is responsible for the holder's safety system across the EU. The QPPV oversees the pharmacovigilance system master file, makes sure case reports and periodic safety update reports go in on time, keeps an overview of safety signals and risk management plans, and is the single point of contact for the authorities around the clock.

Who needs pharmacovigilance training in a supplier company?

Anyone who might hear about a side effect, a product complaint or a pregnancy exposure: sales staff, key account managers, customer service, distributors and the people who answer the company telephone. Supply and quality agreements with European customers normally require such information to be forwarded within a short, fixed number of days, and the customer will ask for the training records that prove your people know the rule.

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

6 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h in the briefing length and 5 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Management, BD, PV. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team